The content on this site is intended for healthcare professionals only

For the latest ecancer COVID-19 resources, click on this link

News

ecancer sources relevant oncology news from key institutes, journals, governments, NGOs and charities, along with commissioned pieces from our dedicated news team.
Latest news
Open-label placebo treatment reduces cancer-related fatigue in patients with advanced cancers
Open-label placebo treatment reduces cancer-related fatigue in patients with advanced cancers
ASCO 2022: Acupuncture improves chronic radiation-induced dry mouth for patients with head and neck cancer
ASCO 2022: Acupuncture improves chronic radiation-induced dry mouth for patients with head and neck ...
ASCO 2022: Targeting p53 pathway shows promise for patients with Merkel cell carcinoma
ASCO 2022: Targeting p53 pathway shows promise for patients with Merkel cell carcinoma
ASCO 2022: Novel immunotherapy combination improved survival in patients with metastatic melanoma
ASCO 2022: Novel immunotherapy combination improved survival in patients with metastatic melanoma
ASCO 2022: Patient-facing screening tool could increase detection of individuals with inherited cancer risk
ASCO 2022: Patient-facing screening tool could increase detection of individuals with inherited canc...
ASCO 2022: Study offers guidance for future trials of adjuvant therapy for patients with early HR+/HER2- breast cancer
ASCO 2022: Study offers guidance for future trials of adjuvant therapy for patients with early HR+/H...
ASCO 2022: Endocrine sensitivity test predicts survival benefit of dose-dense chemotherapy for patients with HR+ breast cancer, study finds
ASCO 2022: Endocrine sensitivity test predicts survival benefit of dose-dense chemotherapy for patie...
ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma
ASCO 2022: Immunotherapy drug combination is safe with promising results in glioblastoma
Next-generation immunotherapy drug shows continued promise in several advanced-stage cancers
Next-generation immunotherapy drug shows continued promise in several advanced-stage cancers
Not individual genes but the “mutational signatures” of many genes hold the key to better cancer therapies
Not individual genes but the “mutational signatures” of many genes hold the key to better cancer the...

More from ecancer

Stay up to date with our ecancer newsletter

Learn more

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

Learn more

Support ecancer's work by making a donation